AP teenagers to start getting jabs from today
2 years, 11 months ago

AP teenagers to start getting jabs from today

Deccan Chronicle  

VIIJAYAWADA: Teenagers in the 15-18 years age-group will start getting Covid vaccination doses across the state from Monday. She said booster doses would be given to healthcare and frontline workers who had taken the second dose at least 39 weeks before January 10. Health and family welfare state commissioner Katamneni Bhaskar said that nearly 19 lakh ANMs would administer the vaccine in their secretariat limits at the doorsteps of teenagers. Krishna district joint collector L Sivasankar said that Covaxin will be administered on the teenagers at their nearest primary health centre.

Health Dose Start Getting  jabs  teenagers  state  covaxin  lakh  doses  given  district  start  getting  today  ap  health  dose  welfare

History of this topic

Over 30% of Covaxin takers faced nervous system disorders, menstrual abnormalities: Study
7 months, 1 week ago

Over 30% of Covaxin takers faced nervous system disorders, menstrual abnormalities: Study

Live Mint  

A study conducted by a team of researchers at the Banaras Hindu University states that nearly 30 per cent of the 926 recipients of Bharat Biotech's Covaxin reported experiencing “adverse events of special interest” or AESI. Among the adolescents, the most common AESIs were: Skin and subcutaneous disorders, general disorders, and nervous system disorders. New-onset skin and subcutaneous disorders, general …

BHU study: Over 30 per cent of Covaxin recipients report adverse events
7 months, 1 week ago

BHU study: Over 30 per cent of Covaxin recipients report adverse events

India TV News  

A recent study conducted by researchers at Banaras Hindu University revealed that over 30% of individuals who received Bharat Biotech's Covaxin reported adverse events. The one-year follow-up study, encompassing 926 participants, shed light on the long-term safety of the BBV152 vaccine, with serious adverse events of special interest such as stroke and Guillain-Barre syndrome reported in one per cent of …

Over 30% Covaxin takers suffered from health issues after one year, claims BHU study
7 months, 1 week ago

Over 30% Covaxin takers suffered from health issues after one year, claims BHU study

New Indian Express  

NEW DELHI: Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study conducted by a team of researchers at Banaras Hindu University. Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at …

Amid Covid surge, Tricity short of vaccine doses
1 year, 8 months ago

Amid Covid surge, Tricity short of vaccine doses

Hindustan Times  

Amid a surge in Covid infections, the Tricity is facing a glaring lack of vaccine availability. Director, health services, Dr Suman Singh has confirmed that the Covid-19 vaccine is currently unavailable, and the department has already communicated this to the Government of India for additional supplies. According to data provided by the health department, a total of 10,89,773 first doses …

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court
1 year, 10 months ago

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court

Live Law  

The Central Government has informed the Delhi High Court that it is not permissible for an individual to take first dose of Covishield and second dose of Covaxin. Central Government’s standing counsel Anurag Ahluwalia told Justice Prathiba M Singh that mixing of two COVID-19 vaccines is not permissible for the first and second dose. The court was hearing a plea …

Nasal vaccines to roll out in private hospitals soon
2 years ago

Nasal vaccines to roll out in private hospitals soon

Hindustan Times  

A new coronavirus vaccine used as a nasal spray will only be available at private health facilities and the Co-WIN platform was set to be tweaked on Friday to allow people to immediately begin booking shots, people aware of the matter said on Friday. On Thursday, India’s technical expert committee on immunization— National Technical Advisory Group on Immunisation —recommended the …

90L in city yet to get booster shot, but BMC has only 6K Covaxin doses
2 years ago

90L in city yet to get booster shot, but BMC has only 6K Covaxin doses

Hindustan Times  

Even as the country is bracing up for a possible surge in Covid-19 cases, the Brihanmumbai Municipal Corporation has only 6,000 Covaxin doses left while there have been no stocks of Covishield or Corbevax for the last few months. BMC’s executive health officer Dr Mangala Gomare said only 16% of the eligible population have received the booster dose and around …

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take
2 years, 1 month ago

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take

India TV News  

Highlights Covaxin lying with the firm are set to expire early next year There are no takers owing to poor demand, said company sources India reported 1,082 fresh COVID-19 cases on Saturday Covaxin news: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers …

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday
2 years, 4 months ago

Corbevax Likely to be Available As Covid Booster Dose at Vaccination Centres from Friday

News 18  

Biological E. Ltd on Thursday said it has delivered 10 crore doses of its Covid-19 vaccine, Corbevax to the Centre so far which is expected to be available as a booster dose on the Cowin App in public and private vaccination centers from Friday. Corbevax was also approved by the Union Health Ministry as a heterologous Covid-19 booster dose under …

Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago

Corbevax as Covid booster for adults from August 12. Check details

India Today  

In a boost to India’s fight against coronavirus, the government gave nod to Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Announcing the decision, Union Health minister Mansukh Mandaviya said, “Further Strengthening India's arsenal against Covid-19, Ministry of Health and Family Welfare approves Corbevax as precaution dose for those …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

Deccan Chronicle  

New Delhi: The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India Today  

The government has approved Biological E's Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precautionary dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India TV News  

Highlights Biological E's Corbevax has been approved as a booster or precaution dose. Covid vaccination: Biological E's Corbevax has been approved as a booster or precaution dose for those above the age of 18, and those who are fully vaccinated with either Covishield or Covaxin. "Corbevax will be considered as a precaution dose after completion of six months or 26 …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry
2 years, 4 months ago

COVID-19: Over 7.20 crore unutilized vaccine doses available with States, Union Territories says health ministry

Firstpost  

The vaccination drive has been ramped up through the availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain New Delhi: The Ministry of Health and Family Welfare on Sunday informed that more than 7.20 crore balance and unutilized COVID-19 vaccine doses are still available …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

PM Modi hails India\'s 200 crore COVID vaccination feat
2 years, 5 months ago

PM Modi hails India\'s 200 crore COVID vaccination feat

Deccan Chronicle  

New Delhi: India crossed the milestone of administering 200 crore Covid-19 vaccine doses at around Sunday noon, almost one-and-a-half years after starting the drive in January 2021. The administration of 200 crore doses includes 101.9 crore doses as the first jab, while 92.6 crore doses as the second and 5.49 crore as precaution dose. As many as 71 per cent …

’Only 10% got Covid-19 booster dose’: CM Arvind Kejriwal’s appeal to Delhi
2 years, 5 months ago

’Only 10% got Covid-19 booster dose’: CM Arvind Kejriwal’s appeal to Delhi

Live Mint  

Delhi Chief Minister Arvind Kejriwal on Sunday appealed to the people to get their Covid-19 precaution doses while highlighting that only around 10% people have done it so far. A total of 1.81 crore have been given first dose and 1.53 crore have received both doses, the Delhi chief minister said while emphasising that Delhi has capacity to administer one …

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership
2 years, 5 months ago

India's Covid Vaccinations Hit 200 Crore Mark in Big Milestone for 7-Phase Drive Under Modi's Leadership

News 18  

India has crossed record 200 crore mark in Covid-19 vaccinations within 18 months of launching the inoculation exercise in January last year. #200CroreVaccinations https://t.co/FtobFYBprV— Dr Mansukh Mandaviya July 17, 2022 A seven-phase vaccination drive was followed on the principle of Prioritization for Vaccine Administration based on scientific advice and global best practices, government officials told News18. While some experts had …

Kejriwal urges Delhiites to get Covid precaution dose, says 'will set up vaccination in schools'
2 years, 5 months ago

Kejriwal urges Delhiites to get Covid precaution dose, says 'will set up vaccination in schools'

India TV News  

Highlights Delhi Chief Minister Arvind Kejriwal on Sunday urged Delhiites to get the precaution dose. Delhi Covid 19 news: Delhi Chief Minister Arvind Kejriwal on Sunday urged Delhiites to get the precaution dose against Covid 19 saying only around 10 per cent of people has done so far in the city. He also urged parents to get their children aged …

India's cumulative Covid-19 vaccination nears 200 crore
2 years, 5 months ago

India's cumulative Covid-19 vaccination nears 200 crore

India Today  

The cumulative Covid-19 vaccine doses administered in the country neared the 200-crore mark on Saturday, the Union health ministry said. Over 14.94 lakh precaution doses of COVID-19 vaccines were given to people in the 18-59 age group till 10 pm, with the majority administered for free under the government's special 75-day drive 'COVID Vaccination Amrit Mahotsav'. The next phase of …

India Set to Achieve Milestone of 200 Crore Covid Vaccinations
2 years, 5 months ago

India Set to Achieve Milestone of 200 Crore Covid Vaccinations

News 18  

India is on the brink of administering 200 crore Covid-19 vaccine doses. Before India’s new milestone is achieved in what is being called the “largest vaccine drive” by the central government, union health minister Mansukh Mandaviya tweeted saying history was about to be created under the leadership of Prime Minister Narendra Modi. The countdown to two billion doses began earlier …

Over 13.3 lakh precaution doses of Covid vaccines administered to beneficiaries in 18-59 age group
2 years, 5 months ago

Over 13.3 lakh precaution doses of Covid vaccines administered to beneficiaries in 18-59 age group

India TV News  

Over 13.3 lakh precaution doses of COVID-19 vaccines were administered to beneficiaries in the age group of 18-59 years till 10 pm on Friday, with a majority of those being free under a special 75-day drive launched by the government. The "COVID Vaccination Amrit Mahotsav" to provide free precaution doses of the vaccines to everyone aged 18 years and above …

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres
2 years, 5 months ago

Free COVID-19 booster shots for all adults for 75 days from July 15 at government centres

The Hindu  

As part of the Azadi Ka Amrit Mahotsav celebrations, free precaution doses of COVID-19 vaccines will be available for all citizens above 18 years of age at government vaccination centres from July 15 for 75 days, Anurag Singh Thakur, Union Minister of Information and Broadcasting, announced on July 13, following a meeting of the Union Cabinet. India’s cumulative COVID-19 vaccination …

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years
2 years, 5 months ago

NTAGI Panel Recommends Use of Covid Vaccines Corbevax, Covaxin for Kids Aged 5-12 Years

News 18  

The NTAGI's Standing Technical Sub-Committee approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday. Data of Biological E's Corbevax and Bharat Biotech's Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16 and members decided that the vaccines …

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here
2 years, 5 months ago

Corbevax, Covaxin vacines get nod for use among 5-12 years olds; details here

Live Mint  

Biological E's Corbevax and Bharat Biotech's Covaxin on July 8 received the nod from the National Technical Advisory Group on Immunisation's Standing Technical Sub-Committee for use among children aged between 5-12 years. The Drugs Controller General of India granted emergency use authorisation to the Biological E's Corbevax for 5-12 year old and Bharat Biotech's Covaxin for minors belonging to the …

Serum Institute gets govt nod to export 32.4 lakh doses of Covovax vaccine to US
2 years, 5 months ago

Serum Institute gets govt nod to export 32.4 lakh doses of Covovax vaccine to US

India Today  

The government has allowed Serum Institute of India to supply 32.4 lakh doses of its Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported to the country by any Indian manufacturer, official sources said on Friday. "It is a matter of pride for us and our country that, in …

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years
2 years, 5 months ago

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Live Mint  

The Serum Institute Of India's Covid-19 vaccine Covovax has been approved on Tuesday by the Drugs Controller General of India for children between the age group of 7 and 12 years. The DCGI's nod for restricted emergency use in children came after the subject expert committee on Covid-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax …

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI
2 years, 5 months ago

Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGI

The Hindu  

Allowing Biological E’s Corbevax as a booster for those fully vaccinated against COVID-19 with either Covishield or Covaxin is likely to be considered by the NTAGI, which is scheduled to meet on Tuesday, sources said. “The National Technical Advisory Group on Immunisation will discuss allowing Corbevax, which has been cleared by the DCGI, as a booster for those fully vaccinated …

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds
2 years, 6 months ago

Govt Panel Recommends Emergency Approval for SII's Covovax for 7-11 Year Olds

News 18  

An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to 11 years, official sources said. "The Subject Expert Committee on Covid-19 of the CDSCO deliberated on the EUA application of SII and recommended granting emergency use authorisation for Covovax for children aged 7 to 11 years," …

Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech
2 years, 6 months ago

Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech

The Hindu  

Bharat Biotech International Limited, on Friday, announced that COVID-vaccine Covaxin has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study. The company in its press release said that Bharat Biotech had conducted phase II/III, open-label, and multi-centre study to evaluate the safety, reactogenicity, and immunogenicity Covaxin in healthy children and adolescents in 2-18 years …

Covaxin safe, well-tolerated in 2-18 years age-group, announces Bharat Biotech
2 years, 6 months ago

Covaxin safe, well-tolerated in 2-18 years age-group, announces Bharat Biotech

Firstpost  

The clinical trial conducted in the paediatric population between June 2021 to September 2021 has shown safety, less reactogenic, and robust immunogenicity Hyderabad: Bharat Biotech International Limited on Friday announced that its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in paediatric subjects in phase II/III study. Bharat Biotech had conducted phase II/III, open-label, and multi-centre …

Close to 200 crore Covid vaccine doses administered in India so far: Health ministry
2 years, 6 months ago

Close to 200 crore Covid vaccine doses administered in India so far: Health ministry

India TV News  

Highlights The countrywide vaccination drive was rolled out on January 16 last year Vaccination of frontline workers started from February 2 last year Vaccination for all people aged more than 45 years began on April 1 last year The cumulative COVID-19 vaccine doses administered in the country reached nearly 196 crore on Friday, the Union Health Ministry said. A total …

NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap
2 years, 6 months ago

NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap

News 18  

Government advisory panel NTAGI will meet on Thursday to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses from the current nine to six months. The agenda for the NTAGI's Standing Technical Sub-Committee meeting includes a discussion on a study by the CMC Vellore …

Germany recognises Bharat Biotech's Covaxin for travel from June 1
2 years, 6 months ago

Germany recognises Bharat Biotech's Covaxin for travel from June 1

India TV News  

Highlights WHO in November last year issued an emergency use listing for Covaxin The step added a growing portfolio of vaccines validated for the prevention of COVID-19 WHO's EUL procedure assesses the quality, safety and efficacy of COVID-19 vaccines Germany has recognised the WHO-listed Bharat Biotech's COVID vaccine Covaxin, for travel to the country starting June 1. World Health Organization …

In 15-18 years age group, over 80% got first dose of Covid vaccine: Mansukh Mandaviya
2 years, 7 months ago

In 15-18 years age group, over 80% got first dose of Covid vaccine: Mansukh Mandaviya

India TV News  

Over 80 percent of people aged between 15 and 18 years have received the first dose of the Covid vaccine, Union Health Minister Mansukh Mandaviya said on Tuesday. The COVID-19 vaccination for the age group 12-14 years was started on March 16 and so far more than 3.30 crore adolescents in this age group have been administered the first dose. …

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report
2 years, 7 months ago

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report

Live Mint  

The government may not allow the administration of a precaution Covid-19 dose that is different from the one used for primary vaccination, reported news agency PTI, quoting sources, on Thursday. This comes in light of a recent study by the Christian Medical College Vellore, which showed that a booster dose of Covishield after primary vaccination with Covaxin gives 6 to …

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients
2 years, 7 months ago

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients

Live Mint  

Hyderabad-based Biological E has submitted an application to India's drug regulator, seeking emergency use authorisation for its Covid-19 vaccine Corbevax as a booster dose for adults who have been given two doses of either Covishield or Covaxin, reported news agency PTI, quoting sources. “We are now submitting the marketing authorization application for grant of permission Corbevax for restricted use in …

Over 190 crore COVID-19 vaccine doses administered across India
2 years, 7 months ago

Over 190 crore COVID-19 vaccine doses administered across India

The Hindu  

The cumulative number of COVID-19 vaccine doses administered in the country has crossed 190 crore, the Union Health Ministry said on May 7. On April 10, India began administering precaution doses of COVID-19 vaccines to people aged above 18 years at private vaccination centres. The next phase of the COVID-19 vaccination commenced on March 1, 2021, for people over 60 …

Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today
2 years, 7 months ago

Jabs for Kids, Reducing Gap Between Doses for Those Travelling Abroad on Agenda as NTAGI Meets Today

News 18  

As India witnesses a surge in coronavirus cases once again, the Covid-19 working group of the National Technical Advisory Group on Immunisation will meet at noon on Wednesday to discuss reducing the gap between the second dose and the precaution dose for people traveling abroad as well as vaccinations for 5-12 and 6-12 age groups. Last week, India’s drug regulator …

SII's Covid Vaccine Covovax Now Available for 12-17 Age Group at Private Centres
2 years, 7 months ago

SII's Covid Vaccine Covovax Now Available for 12-17 Age Group at Private Centres

News 18  

Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday. "Those aged 12-17 age group can now opt for Covovax shot at private hospitals. India's drug regulator had approved Covovax for restricted use in emergency situations …

SEC seeks more data from Serum Institute of India over COVID vaccine 'Covovax' for 7-12 age group: Sources
2 years, 7 months ago

SEC seeks more data from Serum Institute of India over COVID vaccine 'Covovax' for 7-12 age group: Sources

India TV News  

Highlights DCGI subject expert committee on April 29 sought more data from SII on Covovax vaccine SEC has sought more data for Covovax vaccine for 7-12 years age group Covovax has already been recommended by DCGI for children above 12 years of age Coronavirus vaccine: The Drugs Controller General of India's subject expert committee on Friday sought more data from …

Serum Covovax approved as Covid vaccine for children in the age group of 12 to 17
2 years, 7 months ago

Serum Covovax approved as Covid vaccine for children in the age group of 12 to 17

Op India  

National Technical Advisory Group on Immunisation, on Friday 29th April 2022, approved Serum Institute’s anti-COVID-19 vaccine, Covovax, for children in the age group of 12 to 17 years. On 17th December 2021, the World Health Organisation approved the emergency use of Serum Institute of India’s Covovax, a vaccine developed by the Serum Institute of India in partnership with the US-based …

In haste: The Hindu Editorial on vaccinating children against COVID-19
2 years, 7 months ago

In haste: The Hindu Editorial on vaccinating children against COVID-19

The Hindu  

The emergency use authorisation granted on April 26 to two COVID-19 vaccines — Corbevax for children 5-11 years, and Covaxin for children 6-11 years — is one more instance where the Indian drug regulator has acted in haste. Even if the EUA granted to Covaxin in January 2021 despite no safety and efficacy data of the phase-3 trial is condoned …

Gap Between 2nd Dose of Covid Jab, Precaution Dose to Be Reduced to 6 Months Soon
2 years, 7 months ago

Gap Between 2nd Dose of Covid Jab, Precaution Dose to Be Reduced to 6 Months Soon

News 18  

The government is likely to soon reduce the gap between the second dose of COVID-19 vaccine and the precaution dose from the current nine months to six months, official sources said on Wednesday. "Taking into account the scientific evidence and findings of the studies done here and internationally, the gap between the second dose of COVID-19 vaccine and the precaution …

COVID: Over 2,900 new pandemic cases, 32 fatalities in last 24 hours; active cases rise to 16,279
2 years, 7 months ago

COVID: Over 2,900 new pandemic cases, 32 fatalities in last 24 hours; active cases rise to 16,279

India TV News  

Highlights Total active cases of COVID in India have rose to 16,279 today The total death toll in the country is now at 5,23,654 The daily positivity rate is 0.58 per cent on April 27 COVID-19 India News Updates : India recorded 2,927 new cases of the novel coronavirus, along with 32 deaths due to the infection in the past …

India clears 2 vaccines for kids under 12 years
2 years, 7 months ago

India clears 2 vaccines for kids under 12 years

Hindustan Times  

India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat Biotech’s Covaxin, for children under the age of 12 years – a milestone move that paves the way for that cohort in the country to receive a vaccine shot against the disease for the first time. Currently, Bharat Biotech’s Covaxin, an inactivated …

Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids
2 years, 7 months ago

Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids

News 18  

In the wake of schools reporting a spike in coronavirus cases among children, the Drugs Controller General of India has approved the restricted emergency use of three vaccines for different age groups of children — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D. Covaxin has received the emergency use authorisation for the age group of 6 to 12 …

Discover Related